- Home
- KMPR vs HAE Comparison
KMPR vs HAE Comparison
Compare KMPR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMPR
- HAE
- Stock Information
- Founded
- KMPR 1990
- HAE 1971
- Country
- KMPR United States
- HAE United States
- Employees
- KMPR N/A
- HAE N/A
- Industry
- KMPR Property-Casualty Insurers
- HAE Medical/Dental Instruments
- Sector
- KMPR Finance
- HAE Health Care
- Exchange
- KMPR Nasdaq
- HAE Nasdaq
- Market Cap
- KMPR 4.2B
- HAE 3.9B
- IPO Year
- KMPR N/A
- HAE 1991
- Fundamental
- Price
- KMPR $65.26
- HAE $73.49
- Analyst Decision
- KMPR Strong Buy
- HAE Strong Buy
- Analyst Count
- KMPR 5
- HAE 9
- Target Price
- KMPR $76.60
- HAE $108.78
- AVG Volume (30 Days)
- KMPR 320.5K
- HAE 513.7K
- Earning Date
- KMPR 01-30-2025
- HAE 02-06-2025
- Dividend Yield
- KMPR 1.90%
- HAE N/A
- EPS Growth
- KMPR N/A
- HAE N/A
- EPS
- KMPR 4.20
- HAE 2.41
- Revenue
- KMPR $4,639,300,000.00
- HAE $1,361,223,000.00
- Revenue This Year
- KMPR N/A
- HAE $7.56
- Revenue Next Year
- KMPR $12.15
- HAE $3.13
- P/E Ratio
- KMPR $15.54
- HAE $30.49
- Revenue Growth
- KMPR N/A
- HAE 9.84
- 52 Week Low
- KMPR $54.11
- HAE $69.29
- 52 Week High
- KMPR $73.01
- HAE $97.97
- Technical
- Relative Strength Index (RSI)
- KMPR 47.49
- HAE 36.41
- Support Level
- KMPR $62.00
- HAE $69.29
- Resistance Level
- KMPR $67.08
- HAE $82.25
- Average True Range (ATR)
- KMPR 1.51
- HAE 2.96
- MACD
- KMPR 0.15
- HAE -0.32
- Stochastic Oscillator
- KMPR 64.17
- HAE 32.41
About KMPR Kemper Corporation
Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.